3,253 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 587 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,253
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$517M
2 +$511M
3 +$381M
4
JP Morgan Chase
JP Morgan Chase
New York
+$314M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$271M
Name Holding Trade Value Shares
Change
Change in
Stake
2301
$754K
2302
$753K
2303
$750K
2304
$749K
2305
$746K
2306
$745K
2307
$745K
2308
$744K
2309
$744K
2310
$743K
2311
$741K
2312
$739K
2313
$738K
2314
$736K
2315
$735K
2316
$735K
2317
$734K
2318
$733K
2319
$731K
2320
$731K
2321
$726K
2322
$725K
2323
$723K
2324
$722K
2325
$720K